Cristóbal Morales

4.0k total citations
51 papers, 536 citations indexed

About

Cristóbal Morales is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Cristóbal Morales has authored 51 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Cristóbal Morales's work include Diabetes Treatment and Management (29 papers), Diabetes Management and Research (24 papers) and Metabolism, Diabetes, and Cancer (15 papers). Cristóbal Morales is often cited by papers focused on Diabetes Treatment and Management (29 papers), Diabetes Management and Research (24 papers) and Metabolism, Diabetes, and Cancer (15 papers). Cristóbal Morales collaborates with scholars based in Spain, United States and Chile. Cristóbal Morales's co-authors include Fernando Gómez‐Peralta, Tomás Martín Hernández, Gerardo Gómez Moreno, Guillermo E. Umpierrez, Ana María Moreno‐Fernández, Cristina Abreu, Carlos Arana, Diego Bellido, Kamilla Begtrup and Liana K. Billings and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Cristóbal Morales

48 papers receiving 526 citations

Peers

Cristóbal Morales
Yoichiro Hirakawa Japan
Samiul Mostafa United Kingdom
E.S. Sous United States
Catherine Born France
Andreas Liebl Germany
Oliver Schnell Germany
A C Thai Singapore
Samia Bokhari Saudi Arabia
Hamid Reza Aghaei Meybodi Iran
Bethany Warren United States
Yoichiro Hirakawa Japan
Cristóbal Morales
Citations per year, relative to Cristóbal Morales Cristóbal Morales (= 1×) peers Yoichiro Hirakawa

Countries citing papers authored by Cristóbal Morales

Since Specialization
Citations

This map shows the geographic impact of Cristóbal Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristóbal Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristóbal Morales more than expected).

Fields of papers citing papers by Cristóbal Morales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristóbal Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristóbal Morales. The network helps show where Cristóbal Morales may publish in the future.

Co-authorship network of co-authors of Cristóbal Morales

This figure shows the co-authorship network connecting the top 25 collaborators of Cristóbal Morales. A scholar is included among the top collaborators of Cristóbal Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristóbal Morales. Cristóbal Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morales, Cristóbal, et al.. (2025). Efficacy of a Digital Educational Intervention for Patients With Type 2 Diabetes Mellitus: Multicenter, Randomized, Prospective, 6-Month Follow-Up Study. Journal of Medical Internet Research. 27. e60758–e60758. 1 indexed citations
2.
Delgado, Elías, Cristóbal Morales, Cristina Abreu, et al.. (2025). PIONEER REAL Spain : A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes. Diabetes Obesity and Metabolism. 27(9). 4812–4824. 2 indexed citations
3.
Colhoun, Helen M., Scott S. Emerson, G. Kees Hovingh, et al.. (2025). EFFECT OF THE GLP-1 RECEPTOR AGONIST SEMAGLUTIDE ON TOTAL CARDIOVASCULAR EVENTS IN PATIENTS WITH CARDIOVASCULAR DISEASE AND OVERWEIGHT OR OBESITY BUT NO DIABETES IN THE SELECT TRIAL. Journal of the American College of Cardiology. 85(12). 378–378.
4.
Martín, Francisco Javier Escalada San, Irene Bretón Lesmes, Fernando Gómez‐Peralta, et al.. (2025). Resumen ejecutivo del documento «Hospital de Día de Diabetes. Propuesta de valor». Endocrinología Diabetes y Nutrición. 72(8). 501601–501601. 1 indexed citations
5.
Morales, Cristóbal, et al.. (2024). Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus. Frontiers in Endocrinology. 15. 1386542–1386542. 15 indexed citations
6.
Merino-Torres, Juan Francisco, et al.. (2024). Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study). Nutrients. 16(15). 2545–2545. 3 indexed citations
7.
Bellido, Virginia, Cristóbal Morales, Araceli Muñoz‐Garach, et al.. (2023). Descriptive study of a clinical and educational telemedicineintervention in patients with diabetes receiving glargine 300U/ml (Toujeo) in Spain: results of the T-Coach programme. Drugs in Context. 12. 1–11. 2 indexed citations
8.
9.
Orozco‐Beltrán, Domingo, Cristóbal Morales, Carlos Brotons, et al.. (2022). Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study. JMIR Diabetes. 7(4). e40377–e40377. 7 indexed citations
10.
Piñar-Gutiérrez, Ana, et al.. (2022). Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice. Journal of Diabetes Research. 2022. 1–16. 6 indexed citations
11.
Fadini, Gian Paolo, et al.. (2022). Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3533–3541. 1 indexed citations
12.
Morales, Cristóbal, Virginia Bellido, Cristina Tejera Pérez, et al.. (2021). DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain. Journal of Comparative Effectiveness Research. 10(10). 815–821. 2 indexed citations
13.
Morales, Cristóbal, et al.. (2021). Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab. Endocrinología Diabetes y Nutrición (English ed ). 68(5). 363–365. 2 indexed citations
14.
Saldarriaga, Clara, et al.. (2020). De la diabetes a la insuficiencia cardiaca ¿Existe la miocardiopatía diabética?. SHILAP Revista de lepidopterología. 27. 12–16. 2 indexed citations
15.
Bode, Bruce W., Satish K. Garg, Paul Norwood, et al.. (2020). Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study. Diabetes Technology & Therapeutics. 23(1). 41–50. 24 indexed citations
16.
Vélez, Juan Manuel, Enrique Piña, Cristóbal Morales, et al.. (2018). Eficacia de una estrategia para mejorar los indicadores de calidad del Proceso Asistencial Integrado Diabetes Mellitus 2 en el Centro Avanzado de Diabetes Macarena. Atención Primaria. 51(1). 18–23. 4 indexed citations
17.
18.
Morillas, Carlos, Enric Esmatjes, Luís Lizán, et al.. (2015). Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment. Patient Preference and Adherence. 9. 1443–1443. 22 indexed citations
19.
Morales, Cristóbal, Natalia Colomo, G Piédrola, et al.. (2014). Implementación del protocolo hospitalario de insulinización subcutánea para pacientes no críticos en hospitales andaluces de tercer nivel. Endocrinología y Nutrición. 62(2). 64–71. 2 indexed citations
20.
Morales, Cristóbal, et al.. (2009). Detección de deficiencia de yodo en el sur de España mediante el cribado del hipotiroidismo congénito. Anales de Pediatría. 72(2). 121–127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichiro Hirakawa Breakdown of academic impact, for papers by Samiul Mostafa Breakdown of academic impact, for papers by E.S. Sous Breakdown of academic impact, for papers by Catherine Born Breakdown of academic impact, for papers by Andreas Liebl Breakdown of academic impact, for papers by Oliver Schnell Breakdown of academic impact, for papers by A C Thai Breakdown of academic impact, for papers by Samia Bokhari Breakdown of academic impact, for papers by Hamid Reza Aghaei Meybodi Breakdown of academic impact, for papers by Bethany Warren
Rankless by CCL
2026